AzTrials
AzTrials

First Episode Psychosis (FEP)APIPEPNCT07041463

Psychoeducation Program for Family Caregivers Coordinated by an APRN

A study testing Psychoeducation program coordinated by an APRN in people with First Episode Psychosis (FEP) and Caregiver Burden, run by Hôpital le Vinatier at 5 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study is to assess the impact of implementing a specific family program coordinated by APRNs, covering the 5 levels of the family care pyramid through a consultation, an individual psychoeducation program and a group psychoeducation program, on improving caregiver burden and thus contributing to the… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Psychoeducation program coordinated by an APRN
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
5 sitesFrance
Study dates
5 Jun 2026to 4 Nov 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Caregiver relative of a patient under the care of the FEP team and meeting the criteria of international recommendations of FEP diagnosis made by the specialized team of less than 6 months, between 18 and 35 years of age.
  • Caregiver having received information about the study and having giveń consent.
  • Caregiver covered by a health insurance plan

Who cannot join

  • Caregiver under curatorship, guardianship, safeguard of justice, family habilitation or future protection mandate
  • Caregiver participating in another study that may interact with this one
  • Caregiver not fluent in French (comprehension/reading)
  • Caregiver who has already received psycho-education on FEP
  • Patient's opposition to caregiver's participation in research

Trial locations and contacts

5 sites in 1 country. Contact the study team or a site near you to ask about taking part.

5 sites in 1 country

France5 sites, 5 recruiting
  • CHRU de Brest - Hôpital de BOHARS,

    Bohars, 29820

    Lucie DUSSAUZE, Nurse, 0607060398 ext. +33, lucie.dussauze@chu-brest.fr

    Lucie DUSSAUZE, Nurse

    Not yet recruiting
  • CH le Vinatier

    Bron, 69678

    Caroline DAMASCENO, 07 85 58 68 10 ext. +33, caroline.damasceno@ch-le-vinatier.fr

    Caroline DAMASCENO

    Recruiting
  • Groupe Hospitalier Marius Lacroix

    La Rochelle, 17000

    Hugues MONJARET, Nurse, 07 89 29 08 75 ext. +33, Hugues.monjaret@ght-atlantique17.fr

    Hugues MONJARET

    Not yet recruiting
  • Hôpital La Colombière

    Montpellier, 34295

    Nathalie FOURNIER, Nurse, 0616740672 ext. +33, ice-uja@chu-montpellier.fr

    Nathalie FOURNIER, Nurse

    Not yet recruiting
  • CHU de Nîmes

    Nîmes, 30029

    NAdia LIPPLER, Nurse, 0466686868 ext. +33, nadia.LIPPLER@chu-nimes.fr

    Nadia LIPPLER, Nurse

    Not yet recruiting

Other trials in France

About this study

Official title: Impact of a New Psychoeducation Program Coordinated by an Advanced Practce Nurse on the Burden of Family Caregivers of Patients With a First Pyschotic Episode.

The aim of this study is to assess the impact of implementing a specific family program coordinated by APRNs, covering the 5 levels of the family care pyramid through a consultation, an individual psychoeducation program and a group psychoeducation program, on improving caregiver burden and thus contributing to the recovery of users suffering from FEP.

Detailed Description: Psychotic disorders are among the most disabling chronic pathologies in psychiatry. These disorders modify the individual's perceptions, thoughts, moods, behaviours and day-to-day functioning (Implementing interventions as early as possible in the first psychotic episode (FEP) would be likely to decrease the severity and consequences of the illness and improve prospects for recovery. Evidence supports the establishment of multidisciplinary teams to detect early and treat early those experiencing FEP and those at increased risk of psychosis. Recommended interventions include cognitive-behavioral therapies, family interventions, employment and educational support, and above all, at the heart of the system, case management. These specialized teams need to be multidisciplinary, bringing together psychiatrists, psychologists and social workers in addition to case managers. More recently in France, Advanced practice nurse (APRN) have joined these teams. But getting young people to accept both disorders and care is a difficult necessity, and remains a major challenge. Poor compliance with treatment is said to be one of the primary causes of relapse after FEP. Factors that increase the risk of relapse include initially more severe symptoms, persistent substance abuse, poor adherence to treatment and inadequate support from family and friends. Nowadays, support from a close caregiver for a person living with a psychic disorder is recognized as a very favorable factor for long-term prognosis. But the occurrence of a FEP often has the effect of a tidal wave for loved ones, who present high levels of psychological distress and feelings of burden. Unfortunately, it is still difficult for families to gain access to family caregiver support services, which are still insufficiently available and often unknown to them. A number of barriers stand in the way of systematically proposing family interventions, such as health professionals' lack of awareness of the effectiveness of interventions aimed at family carers, their difficulty in establishing a double therapeutic alliance with the young person and his or her family, or the misperception that family interventions are in contradiction with professional secrecy.

The pyramid of family care in early intervention presents the family support that should be available to families of young people with FEP. The levels of intervention are designed to meet the support needs of family caregivers and can be used flexibly depending on specific needs or the phase of the psychotic episode. Also, APRNs could contribute to the success of these caregiver support programs thanks to their skills in prevention, assessment and coordination of complex pathways. This study therefore aims to determine the extent to which a specific program coordinated by APRNs can influence the burden of a family caregiver of a young person suffering from FEP.

Read the detailed description

Implementing a specific family program coordinated by APRNs, covering the 5 levels of the family care pyramid through a consultation, an individual psychoeducation program and a group psychoeducation program, on improving caregiver burden and thus contributing to the recovery of users suffering from FEP.

Being tested
Psychoeducation program coordinated by an APRN, Usual Care
Keywords
First Episode Psychosis (FEP), Caregiver burden, Advanced Practice Nurse
Medical subject headings
Caregiver Burden

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Psychoeducation program coordinated by an APRNOther

    Individual and group psycho-education programs. Each investigating center will be trained in the same tools, in order to harmonize practices:

    • BREF: This is a 3-session psycho-educational program in which each family is received individually by a pair of caregivers who are not involved in the patient's care.
    • PEPs Caregiver: This is a group psycho-education program in 5 2-hour sessions developed in the coordinating center.
  • Usual CareOther

    The caregiver will benefit from the interventions and referrals provided for caregivers "as usual" at each center.

Study groups in NCT07041463
Study groupRoleWhat they receive
Psychoeducation program coordinated by an APRNExperimentalThe intervention includes an APRN reception, listening and orientation consultation, harmonized during a preparatory meeting prior to setting up the study. At the very least, this should include empathetic listening to the young person's problems, a tour of the unit, an explanation of the young person's background and an explanation of the approach. * Individual and group psycho-education programs. Each investigating center will be trained in the same tools, in order to harmonize practices: * BREF: This is a 3-session psycho-educational program in which each family is received individually by a pair of caregivers who are not involved in the patient's care. * PEPs Caregiver: This is a group psycho-education program in 5 2-hour sessions developed in the coordinating center.
Receives: Other: Psychoeducation program coordinated by an APRN; Other: Usual Care
USUAL interventionOtherThe intervention includes an APRN reception, listening and orientation consultation, harmonized during a preparatory meeting prior to setting up the study. At the very least, this should include empathetic listening to the young person's problems, a tour of the unit, an explanation of the young person's background and an explanation of the approach. In the control phase, the caregiver will benefit from the interventions and referrals provided for caregivers "as usual" at each center.
Receives: Other: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Caregiver's burden

    The ZARIT scale is a validated, self-reported questionnaire that assesses the emotional, physical and financial burden of caring for a sick person. It consists of 22 items, with response modalities on a Likert scale), rated from 0 to 4, giving a score from 0 to 88. A low score represents a limited level of perceived burden, while a high score reflects a heavy burden.

    Measured: 2 times : Baseline and at 6 months

Secondary outcomes (14)
  1. Caregiver's burden

    Change in ZARIT score of caregiver between inclusion and 3 months, between inclusion and 12 months the same as primary outcome measure

    Measured: 2 times : at 3 months and at 12 months

  2. The mood of the caregiver

    The CES-D (center of epidemiologic studies depression) scale is a self-administered questionnaire that assesses the subject's mood by asking how often, in the past week, he or she has experienced symptoms or behaviors associated with depression. Symptom frequency is measured using a 4-point Likert scale (0=never to 3=frequently). The overall score ranges from 0 to 60. Higher scores correspond to more severe symptoms

    Measured: 4 times : at inclusion, at 3 months, at 6 months and at 12 months

  3. The caregiver's personal effectiveness

    General Self-Efficacy Scale GSE French version. This is a self-administered questionnaire where each statement refers to a successful adaptation and implies a stable internal attribution of success. It uses a 1-4 response scale of "Not at all true" "Barely true", "Moderately true" and "Totally true". The total score is calculated by adding up the responses to each statement: it can therefore vary from 10 to 40.

    Measured: 4 times : at inclusion, at 3 months, at 6 months and at 12 months

  4. Quality of life for caregivers

    The World Health Organization Quality of Life WHOQOL-BREF. This 26-item questionnaire is completed by the respondent. It comprises 4 domains: "physical health", "psychological well-being", "social relationships" and "environment". Items are answered using a five-level scale (from "not at all" to "rather no", 'about', "most of the time" to "completely"). The scales are highly internally consistent.

    Measured: 2 times : at inclusion, at 12 months

  5. Involvement in patient care

    The Service Engagement Scale SES. This is a 14-point measure that assesses service-user engagement from the staff's point of view. The case manager involved in the service user's care assesses his or her agreement with the statements using a four-point Likert scale about the user's availability, collaboration with the user, help-seeking and adherence to treatment.

    Measured: 2 times : at inclusion, at 12 months

  6. User recovery

    The Stages Of Recovery Instrument STORI. This self-administered questionnaire assesses the stage of recovery reached by a patient with a psychotic disorder. The STORI is made up of 50 items, presented in 10 groups of 5. Each group represents one of the four recovery processes (Hope, Identity, Meaning, Responsibility).

    Measured: 2 times : at inclusion, at 12 months

  7. Implementation of the intervention

    Acceptability: rate of acceptance of participation in the study by family caregivers, number of refusals and early stops in the program, proportion of family caregivers benefiting from the entire program

    Measured: 1 time : at 12 months

  8. Acceptance of study participation

    Acceptance of study participation by caregivers will be measured by the proportion of caregivers who agreed to participate in the study among those who were offered the study

    Measured: 1 time : at 12 months

  9. Feasibility of the program

    Feasibility of the program will be measured by the average length of time between stages of the program

    Measured: 1 time at 12 months

  10. qualitative evaluation of the implementation

    qualitative evaluation of the implementation during semi-structured interviews with the APRNs at each center and the family caregivers in the experimental group. This qualitative survey will enable us to determine satisfaction with the program, understand the perceived effects of the program and its acceptability, and explore the perceived obstacles and limitations of the program and its implementation. These elements will be studied at both individual (caregivers, users and professionals) and organizational (services, environment) levels. The posture, missions and role of the APRNs with patients, families and within the FEP team will be studied in semi-directed interviews.

    Measured: 1 time : at 12 months

  11. Program transferability

    Program transferability (the extent to which the effects of an intervention in one context can be observed in another) will be analyzed using the Tool for Analyzing Transferability and Supporting the Adaptation of Health Promotion InteRventions (ASTAIRE Grid). This tool assesses the transferability of an intervention based on the characteristics of the target population, the environment in which the intervention is implemented and the support required for transfer

    Measured: 1 time : at 12 months

  12. The relapse

    Relapse will be defined as any general worsening of the person's condition (decline in level of functioning) requiring intervention such as hospitalization, day hospital follow-up or mobile team intervention for the duration of study participation

    Measured: 1 time : at 12 months

  13. Adherence to the program

    Adherence to the program will be measured by the percentage of participants who completed the program among all caregivers included.

    Measured: 1 time : at 12 months

  14. The fidelity of the program

    The fidelity of the program delivered will be measured by the number of sessions of the program delivered compared with the initial program.

    Measured: 1 time at 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2025
  2. Study start5 Jun 2026
  3. Primary completion4 Nov 2030 (estimated)
  4. Study completion4 Nov 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Multicenter randomized controlled stepped wedge cluster trial
Masking
None (open label)
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07041463
Sponsor's protocol ID
2025-A00412-47
Other IDs
PHRIP-22-0039
Acronym
APIPEP
Status last verified
Jun 2026
First submitted
28 May 2025
Last updated
9 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Caroline D, Julie H, Fabien S, Romain R, Frederic H. Reducing Caregiver Burden in First-Episode Psychosis: Effects of a Psychoeducational Pathway Led by an Advanced Practice Nurse-A Multicentre Stepped-Wedge Randomized Trial. Int J Ment Health Nurs. 2026 Oct;35(5):e70373. doi: 10.1111/inm.70373.

    PubMed 42861836

Questions about this trial

What is this clinical trial studying?

A study testing Psychoeducation program coordinated by an APRN in people with First Episode Psychosis (FEP) and Caregiver Burden, run by Hôpital le Vinatier at 5 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Caroline DAMASCENO, Nurse (07 85 58 68 10 ext. +33, caroline.damasceno@ch-le-vinatier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Caregiver's burden (time frame: 2 times : Baseline and at 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07041463, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in